Kira Gritsman
Affiliations: | 2000 | New York University, New York, NY, United States |
Google:
"Kira Gritsman"Mean distance: 16.21 (cluster 11) | S | N | B | C | P |
Parents
Sign in to add mentor| Alexander Schier | grad student | 2000 | NYU | |
| (Role and regulation of Nodal signaling during zebrafish development.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Gritsman K. (2019) FLT3-ITD gets by with a little help from PRMT1. Blood. 134: 498-500 |
| Gurska LM, Ames K, Gritsman K. (2019) Signaling Pathways in Leukemic Stem Cells. Advances in Experimental Medicine and Biology. 1143: 1-39 |
| Hemmati S, Sinclair T, Tong M, et al. (2019) PI3 kinase alpha and delta promote hematopoietic stem cell activation. Jci Insight. 5 |
| Shah UA, Chung EY, Giricz O, et al. (2018) North American ATLL has a distinct mutational and transcriptional profile and responds to epigenetic therapies. Blood |
| Mitchell K, Barreyro L, Todorova TI, et al. (2018) IL1RAP potentiates multiple oncogenic signaling pathways in AML. The Journal of Experimental Medicine |
| Hemmati S, Sinclair T, Tong M, et al. (2018) PI3Kinase Alpha and Delta Promote Hematopoietic Stem Activation Under Stress Blood. 132: 329-329 |
| Hemmati S, Haque T, Gritsman K. (2017) Inflammatory Signaling Pathways in Preleukemic and Leukemic Stem Cells. Frontiers in Oncology. 7: 265 |
| Bhagat T, Chen S, Bartenstein M, et al. (2017) Wnt/ß-catenin activation by epigenetically aberrant stroma drives myelodysplastic syndrome. Cancer Research |
| Stanley RF, Piszczatowski RT, Bartholdy B, et al. (2017) A myeloid tumor suppressor role for NOL3. The Journal of Experimental Medicine |
| Akula MK, Shi M, Jiang Z, et al. (2016) Control of the innate immune response by the mevalonate pathway. Nature Immunology |